Skip to main content
. 2014 Oct;6(4):195–202.

Table 2 . Adverse effects reported by the patients during treatment .

Adverse effect OAF-400 OAF-600 p -value
Malaise 0 (0%) 7 (6.7%) 0.007
Nausea & Vomiting 2 (1.9%) 19 (18.1%) 0.04
Bitter taste 0 (0%) 2 (1.9%) 0.15
Dizziness 4 (3.8%) 12 (11.4%) 0.03
Dyspepsia 0 (0%) 3 (2.9%) 0.08
Rash 0 (0%) 1 (0.9%) 0.31
Arthralgia 1 (0.9%) 2 (1.9%) 0.56
Orthostatic hypotension 0 (0%) 8 (7.6%) 0.004
Urticaria 1 (0.9%) 1 (0.9%) 0.1
Pruritus 1 (0.9%) 0 (0%) 0.31
Headache 1 (0.9%) 6 (5.7%) 0.055
Abdominal pain 1 (0.9%) 1 (0.9%) 1
Chest pain 0 (0%) 1 (0.9%) 0.31
Diarrhea 1 (0.9%) 2 (1.9%) 0.56
Bloating 2 (1.9%) 0 (0%) 0.15
Fever 1 (0.9%) 8 (6.7%) 0.01
Anorexia 1 (0.9%) 2 (1.9%) 0.56
Severity of side effects N (%) Mild 4(3.8%) 34 (31.4%) 0.001
Moderate 4(3.8%) 14 (13.3%)
Severe 9 (8.6%) 6 (5.7%)
Drug interruption due to side effects 4 (3.8%) 3 (2.8%)